BerandaCAMX • STO
add
Camurus AB
Tutup sebelumnya
kr 467,00
Rentang hari
kr 480,00 - kr 498,60
Rentang tahun
kr 430,80 - kr 754,50
Kapitalisasi pasar
29,91 M SEK
Volume Rata-Rata
121,87 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (SEK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 464,46 jt | -16,03% |
Biaya operasional | 315,31 jt | -12,24% |
Penghasilan bersih | 100,88 jt | -31,36% |
Margin laba bersih | 21,72 | -18,25% |
Penghasilan per saham | 1,67 | -31,84% |
EBITDA | 119,44 jt | -27,19% |
Tarif pajak efektif | 20,47% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,73 M | 30,61% |
Total aset | 4,74 M | 26,16% |
Total liabilitas | 504,56 jt | 7,97% |
Total ekuitas | 4,24 M | — |
Saham yang beredar | 59,64 jt | — |
Harga terhadap nilai buku | 6,58 | — |
Tingkat pengembalian aset | 6,02% | — |
Tingkat pengembalian modal | 6,58% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 100,88 jt | -31,36% |
Kas dari operasi | 255,43 jt | 147,39% |
Kas dari investasi | -45,79 jt | -130,25% |
Kas dari pembiayaan | 3,09 jt | -79,97% |
Perubahan kas bersih | 211,26 jt | 108,27% |
Arus kas bebas | 104,90 jt | 273,91% |
Tentang
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Didirikan
1991
Situs
Karyawan
285
